Last €41.71 EUR
Change Today +0.478 / 1.16%
Volume 250.0
AG8 On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 10:36 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5301 Stevens Creek Boulevard

Santa Clara, CA 95051

United States

Phone: 408-345-8886

Fax: 408-345-8474

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions to the life sciences, diagnostics and genomics, chemical analysis, communications and electronics industries. Segments LIFE SCIENCES AND DIAGNOSTICS BUSINESS This segment provides application-focused solutions that include reagents, instruments, software, consumables, and services that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. The company focuses on the pharmaceutical, academic and government, bio-agriculture, food safety, clinical markets, biotechnology and contract research organization (CRO) industries. Key product categories include liquid chromatography systems, columns and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; nuclear magnetic resonance (NMR), magnetic resonance imaging (MRI), and X-ray diffraction (XRD) systems; services and support for the aforementioned products; immunohistochemistry (IHC); in situ hybridization; hematoxylin and eosin staining; special staining, DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation profiling; gene expression profiling; next generation sequencing target enrichment; and automated gel electrophoresis-based sample analysis systems. The company also collaborates with various pharmaceutical companies to develop new potential pharmacodiagnostics, also called companion diagnostics, with the potential of identifying patients most likely to benefit from a specific targeted therapy. Life Sciences and Diagnostics Markets The company’s life sciences and diagnostics business focuses primarily on three markets, including the pharma, biotech, CRO and contract manufacturing organizations (CMO) market; the academic and government market; and the clinical market. The Pharma, Biotech, CRO and CMO Market: This market consists of for-profit companies who participate across the pharmaceutical value chain in the areas of therapeutic research, discovery and development, clinical trials, manufacturing and quality assurance and quality control. One sub-segment of this market is core and emerging pharmaceutical companies (pharma). A second sub-segment includes biotechnology companies (biotech), CROs and CMOs. The Academic and Government Market: This market consists primarily of not-for-profit organizations and includes academic institutions, large government institutes and privately funded organizations. The academic and government research market plays an influential role in technology adoption and therapeutic developments for pharmaceutical and molecular diagnostics companies. After decades of investment in basic biomedical research by government funding bodies, the focus has widened to include translational research - multidisciplinary scientific efforts directed at accelerating therapy development. The Clinical Market: A significant part of the company’s clinical diagnostic customers are in pathology labs throughout the world. The company’s automated pathology tissue staining platforms and solutions are used most heavily by the large labs located in hospitals, medical centers, and reference labs. The clinical market for genomics consists of high complexity clinical labs performing patient testing, including for-profit reference laboratories, hospital labs, and molecular diagnostic companies. Life Sciences and Diagnostics Measurement Products and Applications The company’s products fall into eleven main areas of work: liquid chromatography, mass spectrometry, software and informatics, lab automation and robotics, automated electrophoresis, NMR and MRI systems, life sciences consumables and services, pathology products, specific proteins and flow reagents, target enrichment, cytogenetic research solutions and microarrays. Liquid Chromatography Products: A liquid chroma

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AG8:GR €41.71 EUR +0.478

AG8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analog Devices Inc $54.29 USD -0.11
Applied Materials Inc $22.85 USD -0.02
Becton Dickinson and Co $119.36 USD +0.49
KLA-Tencor Corp $74.61 USD -0.11
NVIDIA Corp $19.05 USD +0.045
View Industry Companies
 

Industry Analysis

AG8

Industry Average

Valuation AG8 Industry Range
Price/Earnings 26.8x
Price/Sales 2.8x
Price/Book 3.3x
Price/Cash Flow 26.4x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGILENT TECHNOLOGIES INC, please visit www.home.agilent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.